- Home
- PFS vs NVCR Comparison
PFS vs NVCR Comparison
Compare PFS & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFS
- NVCR
- Stock Information
- Founded
- PFS 1839
- NVCR 2000
- Country
- PFS United States
- NVCR Jersey
- Employees
- PFS N/A
- NVCR N/A
- Industry
- PFS Savings Institutions
- NVCR Medical/Dental Instruments
- Sector
- PFS Finance
- NVCR Health Care
- Exchange
- PFS Nasdaq
- NVCR Nasdaq
- Market Cap
- PFS 2.4B
- NVCR 2.1B
- IPO Year
- PFS N/A
- NVCR 2015
- Fundamental
- Price
- PFS $17.83
- NVCR $14.72
- Analyst Decision
- PFS Strong Buy
- NVCR Hold
- Analyst Count
- PFS 4
- NVCR 5
- Target Price
- PFS $20.25
- NVCR $25.40
- AVG Volume (30 Days)
- PFS 724.3K
- NVCR 702.1K
- Earning Date
- PFS 10-29-2024
- NVCR 10-30-2024
- Dividend Yield
- PFS 5.36%
- NVCR N/A
- EPS Growth
- PFS N/A
- NVCR N/A
- EPS
- PFS 0.93
- NVCR N/A
- Revenue
- PFS $427,771,000.00
- NVCR $549,964,000.00
- Revenue This Year
- PFS N/A
- NVCR $16.23
- Revenue Next Year
- PFS $27.22
- NVCR $6.09
- P/E Ratio
- PFS $19.32
- NVCR N/A
- Revenue Growth
- PFS N/A
- NVCR 8.33
- 52 Week Low
- PFS $13.07
- NVCR $10.87
- 52 Week High
- PFS $19.59
- NVCR $24.74
- Technical
- Relative Strength Index (RSI)
- PFS 44.40
- NVCR 35.27
- Support Level
- PFS $17.42
- NVCR $14.44
- Resistance Level
- PFS $18.71
- NVCR $15.75
- Average True Range (ATR)
- PFS 0.50
- NVCR 0.83
- MACD
- PFS -0.13
- NVCR -0.19
- Stochastic Oscillator
- PFS 19.71
- NVCR 6.33
About PFS Provident Financial Services Inc
Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The Company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The Company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The Company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.